Google DeepMind、Meta 与 Isomorphic Labs 联合向 Biohub 投资 3 亿美元
Google invests millions in Mark Zuckerberg’s efforts to create a ‘virtual cell’
Google DeepMind、Meta 和 AI 药物发现初创公司 Isomorphic Labs 共同向扎克伯格夫妇创立的非营利生物医学研究机构 Biohub 投资 3 亿美元，这是 18 亿美元计划的一部分，用于构建可让研究者以数字化方式预测和回答生物学问题的 AI 数据集。Biohub 成立于 2016 年，目标是打造可供研究者进行模拟的虚拟细胞；美国能源部将在未来五年投入超过 5 亿美元，美国国立卫生研究院则提供来自此前联邦投资的数据集、存储库和知识库，总额超过 5 亿美元。
推荐理由
AI 评分 60
Google DeepMind、Meta 与 Isomorphic Labs 联合出资 Biohub，读者可了解 AI 生物数据集这一方向的资金与机构协作格局。
主题
正文
当前显示原文，中文全文译文尚未就绪。
Google DeepMind, Meta, and AI drug discovery startup Isomorphic Labs are jointly investing $300 million into Biohub, the nonprofit biomedical research organization founded by Mark Zuckerberg and his wife, Priscilla Chan, as reported by Reuters . The funding is part of a $1.8 billion initiative to build AI datasets that could allow researchers to “ask, predict, and answer biological questions digitally,” helping find new ways to prevent and manage diseases.
Founded in 2016 , Biohub aims to combat diseases through the creation of a “virtual cell” that researchers can use to carry out simulations. To support this effort, the US Department of Energy will invest more than $500 million over the next five years, while the National Institutes of Health will contribute datasets , repositories, and knowledge bases stemming from previous federal investment totalling over $500 million.
“An accurate predictive model of biology could dramatically accelerate scientific discovery by enabling scientists to perform experiments digitally,” Alex Rives, Biohub’s head of science, says in the press release. “The creation of a virtual cell is one of the most important challenges for the next era of science. It will require coordinated data generation efforts at a national and international scale, which is why these partners are coming together.”